StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of NASDAQ:BLPH opened at $0.04 on Wednesday. The stock’s 50-day simple moving average is $0.04 and its two-hundred day simple moving average is $0.05. The stock has a market capitalization of $440,388.00, a price-to-earnings ratio of -0.04 and a beta of 0.70. Bellerophon Therapeutics has a 52-week low of $0.03 and a 52-week high of $0.10.
Bellerophon Therapeutics Company Profile
Recommended Stories
- Five stocks we like better than Bellerophon Therapeutics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Texas Roadhouse Stock Steering for New Highs This Year
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- How to Invest in Biotech Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
